Published • loading... • Updated
11% of Americans Under Ozempic or Wegovy in 2026, According to Gallup
Summary by SciencePost
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
According to a Gallup poll conducted among 5,065 American adults in June 2026, 11% of Americans are currently taking a GLP-1-like drug to lose weight. They were only 3% in 2024. In two years, these treatments — Ozempic, Wegovy, Zepbound — have changed to the point where they have changed to the point of the first [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
